I thought it would pop a little more than that, however, we are just looking at a phase 2 event, not a Ph3. Moreover, it's not Tuesday yet, and it always helps with a little more info from the company after a conference presentation, or as they call it, a "poster presentation?" These stocks get shorted every time there is something positive and a nice little bump. To keep it going higher would have to take significant news. I'm hoping for the big one: a buyout.
"The abstract, authored by Bernstein et al, "A randomized (RCT) phase II study of oncolytic reovirus (pelareorep) plus standard weekly paclitaxel (P) as therapy for metastatic breast cancer (mBC)" is now available on the AACR website. CCTG will be making a poster presentation, #8466, at the AACR Annual Meeting, on Tuesday Apr 4, 2017 from 1:00 PM - 5:00 PM , in Washington, DC."
News 
Market Data 
Discover 
